Welcome to our dedicated page for Corteva news (Ticker: CTVA), a resource for investors and traders seeking the latest updates and insights on Corteva stock.
Corteva Inc (CTVA) generates news across the agricultural technology and crop science sectors. As one of the largest pure-play agriscience companies, Corteva's announcements span seed technology developments, crop protection innovations, strategic partnerships, and financial performance updates.
Investors and agricultural professionals track Corteva news for insights into several key areas. Quarterly earnings releases reveal performance across the company's seed and crop protection segments, with seasonal patterns reflecting Northern and Southern Hemisphere planting cycles. Partnership announcements often signal new technology development directions, particularly in biotechnology, biological pest control, and sustainable agriculture solutions.
Corteva's research pipeline generates announcements about new seed traits, crop protection chemistries, and biological solutions addressing pest resistance and regulatory changes. Strategic transactions, including joint ventures and technology licensing agreements, reflect how the company positions itself in the evolving agriscience landscape.
Corporate governance updates, dividend declarations, and investor event announcements provide information about capital allocation and shareholder returns. Bookmark this page to follow Corteva's developments in agricultural science, competitive positioning in the global farm inputs market, and progress on sustainability initiatives affecting the agricultural industry.
Etlas is a new 50:50 joint venture between Corteva (NYSE: CTVA) and bp (NYSE: BP) to produce crop-based oil feedstocks for sustainable aviation fuel (SAF) and renewable diesel (RD). Etlas will use canola, mustard and sunflower grown on existing cropland between main food seasons and aims to begin initial supply in 2027 for co-processing and dedicated biofuels plants. The venture targets 1 million metric tonnes of feedstock per year by the mid-2030s, which could yield over 800,000 tonnes of biofuel. Ignacio Conti will be CEO and Gaurav Sonar will chair the board. Etlas is described as a capital-light JV designed to scale feedstock supply to meet growing SAF and RD demand.
Market context: leading estimates project SAF demand rising toward ~10 million tonnes by 2030s and RD demand toward ~35 million tonnes by 2030s, positioning Etlas as a supplier option.
Corteva (NYSE: CTVA) will release its fourth quarter 2025 earnings on Tuesday, February 3, 2026 after market close via press release and the company website. A live webcast of the earnings presentation will be held on Wednesday, February 4, 2026 at 9:00 a.m. Eastern Time with an accompanying slide presentation posted on the Investor Events and Presentations page.
A replay of the webcast will be available on the Investor Events and Presentations page until February 4, 2027.
Corteva (NYSE: CTVA) and Hexagon Bio announced a multi-million-dollar joint venture on December 16, 2025 to accelerate development of nature-inspired crop protection solutions.
The JV combines Corteva’s nature-inspired crop protection franchises and bacterial natural product capabilities with Hexagon Bio’s AI-driven microbial genetics and synthetic biology discovery platform to advance pipelines across agriculture and human health. The JV was formed through Corteva Catalyst, which has partnered with 11 companies since March 2024.
Corteva (CTVA) announced two insect-management products: Goltrevo bioinsecticide, a microbial solution based on Beauveria bassiana 203, and Varpelgo active, a nature‑inspired synthetic for chewing pests.
Goltrevo targets sap‑feeding and chewing pests (whiteflies, aphids, corn leafhopper) with longer shelf life and lower resistance risk; commercial sales forecast as early as 2027 in Latin America pending approvals. Varpelgo targets chewing pests and offers a seed‑applied wireworm solution; first sales expected in early 2030s in Asia Pacific and Latin America, pending trials and regulatory review.
Corteva (NYSE: CTVA) reported strong 3Q and YTD 2025 results and raised full-year guidance on Nov 4, 2025. YTD net sales were $13.49B (up 4%) and Operating EBITDA was $3.40B. GAAP YTD income from continuing ops was $1.74B and GAAP EPS was $2.54. The company now expects 2025 net sales of $17.7B–$17.9B, Operating EBITDA $3.8B–$3.9B, and Operating EPS $3.25–$3.35; a preliminary 2026 Operating EBITDA midpoint view is $4.1B. Seed and Crop Protection showed double‑digit volume gains in new products/biologicals and margin expansion in both segments. The company reiterated separation plans for two public companies in H2 2026 and expects ~$1.0B of share repurchases in 2025.
Corteva (NYSE: CTVA) announced a common stock dividend of $0.18 per share, payable December 15, 2025 to shareholders of record on December 1, 2025. The Board authorized the dividend at its October 31, 2025 meeting.
The release also notes preferred stock dividends declared by EIDP, a wholly owned Corteva subsidiary: $1.125 per share on the $4.50 series and $0.875 per share on the $3.50 series, both payable January 23, 2026 to holders of record on January 8, 2026.
Corteva (NYSE: CTVA) announced a common stock dividend of $0.18 per share, payable December 15, 2025 to shareholders of record on December 1, 2025. The Board authorized the dividend at its October 31, 2025 meeting.
The release also notes preferred stock dividends declared by EIDP, a wholly owned Corteva subsidiary: $1.125 per share on the $4.50 series and $0.875 per share on the $3.50 series, both payable January 23, 2026 to holders of record on January 8, 2026.
Corteva (NYSE: CTVA) has scheduled its third quarter 2025 earnings release for Tuesday, November 4, 2025, after market close. The company will host a live webcast presentation on Wednesday, November 5, 2025, at 9:00 a.m. ET.
The earnings presentation will be accompanied by slides available on Corteva's Investor Events and Presentations webpage. A replay of the webcast will remain accessible on the same page until November 5, 2026.
Corteva (NYSE: CTVA) announced plans to separate into two independent, publicly traded companies through a tax-free spin-off expected to complete in H2 2026. The separation will create:
1. New Corteva: Will comprise the Crop Protection business, with estimated 2025 net sales of $7.8 billion (44% of current sales). The company will focus on operational excellence and innovative solutions, including biologicals.
2. SpinCo: Will contain the Seed business, including the Pioneer® brand, with projected 2025 net sales of $9.9 billion (56% of current sales). Current Corteva CEO Chuck Magro will lead SpinCo, while Greg Page will chair New Corteva.
Both companies will maintain investment-grade credit ratings and pursue distinct growth strategies. The separation aims to enhance strategic focus, optimize capital allocation, and accelerate value creation for shareholders.
Corteva (NYSE: CTVA) has appointed Jennifer Johnson as its new Chief Legal Officer, effective September 15, 2025. Johnson, who previously served as general counsel at International Flavors and Fragrances (IFF), will oversee Corteva's global legal function and join the executive leadership team.
The current chief legal officer, Cornel Fuerer, will retain oversight of public affairs and continue as corporate secretary until the end of 2025, after which he will serve as strategic advisor until his retirement in 2026. Johnson brings significant experience in agriculture technology, having started her in-house legal career at DuPont supporting the Pioneer business, and holds a Ph.D. in plant biology along with extensive experience in biotechnology and patent law.
FAQ
What is the current stock price of Corteva (CTVA)?
What is the market cap of Corteva (CTVA)?
